| Cryo-EM structure of human DRA (SLC26A3) bound with chloride | | homo-2-mer | 7-729 | 100.0 | 2×CL; |
|
| Cryo-EM structure of human DRA (SLC26A3) at pH 6.5 | | homo-2-mer | 7-728 | 100.0 | |
|
| Cryo-EM structure of human DRA (SLC26A3) bound with tenidap | | homo-2-mer | 7-725 | 100.0 | 2×CL; 2×LPE; 2×I2U; |
|
| Cryo-EM structure of human DRA (SLC26A3) bound with oxalate | | homo-2-mer | 7-725 | 100.0 | 2×OXL; 4×POV; 8×C14; 16×D12; 14×LPE; 38×D10; 2×CLR; |
|
| Cryo-EM structure of human DRA (SLC26A3) bound with bicarbonate | | homo-2-mer | 7-725 | 100.0 | 2×BCT; |
|
| Cryo-EM structure of human DRA (SLC26A3) bound with sulfate | | homo-2-mer | 7-725 | 100.0 | 2×SO4; |
|
| Down-regulated in adenoma in complex with TQR1122 | | homo-2-mer | 8-725 | 100.0 | 2×I2L; 8×Y01; |
|
| Human SLC26A3 in complex with UK5099 | | homo-2-mer | 8-725 | 100.0 | 2×I2R; 8×Y01; |
|
| Human SLC26A3 in complex with Tenidap | | homo-2-mer | 8-725 | 100.0 | 2×I2U; 8×Y01; |
|
| Human SLC26A3 in the apo state | | homo-2-mer | 8-722 | 100.0 | |
|